News & Events

Latest news and events from DOCE

DOCE Director Michael Schwartz, MD and Novo Nordisk collaborate on exploring the role of the brain in regulating blood glucose and obesity

Dr. Michael Schwartz is collaborating with Novo Nordisk on a three-year project to explore the role of the brain in regulating blood glucose and obesity. The collaboration aims to understand factors mediating brain control of blood glucose and appetite with the ultimate goal of developing new therapeutic agents for the treatment of diabetes and obesity.…

DOCE Director Michael Schwartz, MD, Featured in Sigma Nutrition.com Podcast

SNR #89: Dr. Michael Schwartz – Role of the Brain in Obesity, Insulin Resistance and Type 2 Diabetes Pathogenesis.

DOCE Associate Director Karin Bornfeldt, PhD, Receives NIH R01 Award

The project, entitled Obesity and Arterial Metabolism, focuses on the overall hypothesis is that expression of the glucose transporter GLUT1 is of critical importance for the obesity-induced arterial metabolic signature, smooth muscle cell phenotype, and obesity-accelerated atherosclerosis.

NHLBI Renews Cardiovascular Disease and Diabetes Program Project (PI: Karin Bornfeldt, DOCE Associate Director)

The focus of the program project is to investigate whether diabetes causes high-density lipoprotein to lose its cardioprotective effects and whether this contributes to the increased cardiovascular disease risk associated with diabetes.

DOCE Researcher Ian Sweet, PhD, and Colleague Receive ADA Innovation Award

Drs. Wang Wang and Ian Sweet have been awarded an American Diabetes Association Innovative Award for their project entitled ‘Source and sites of action of hydrogen peroxide in mitochondria and cytosol of pancreatic islets’.

DOCE Researcher Ian Sweet, PhD, Receives NIH STTR Award

Dr. Ian Sweet has been awarded an NIH Small Business Technology Transfer (STTR) award for his project entitled ‘Continuous measurement of cell growth as an optimal tool in drug toxicity testing’.

DOCE Director Michael Schwartz, MD, Featured in UW Medicine Magazine

The article, entitled “Diabetes & Obesity via the Brain” focuses on the Schwartz Laboratory’s use of optogentics to understand the neurocircuitry activated in diabetes with the goal to develop new opportunities to treat or prevent the disease

DOCE Researcher Christiane Hampe, PhD, Receives T1D Exchange Biobank Pilot Award

Dr. Christiane Hampe has received a one year pilot research award through the T1D Exchange Biobank Operations Center at the Benaroya Research Institute (BRI)